Avricore Health (AVCRF) Net Margin (2009 - 2025)

Avricore Health has disclosed Net Margin across 15 years of filings, most recently posting 1006.6% for Q3 2025.

• In Q3 2025, Net Margin fell 99162.0% year-over-year to 1006.6%; the TTM figure through Sep 2025 stood at 53.87% (down 6546.0% YoY), while the FY2025 annual figure was 46.91%, up 6088.0% from the prior year.
• Net Margin advanced to 1006.6% in Q3 2025, from 1599.78% in the prior quarter.
• Over the last five years, Net Margin for AVCRF reached as high as 8734.94% in Q4 2021 and fell as low as 1599.78% in Q2 2025.
• The 5-year median for Net Margin is 5.17% (2024), against an average of 442.12%.
• The widest YoY moves for Net Margin: up 2138 bps in 2022, down 853995 bps in 2022.
• A 5-year view of Net Margin shows it stood at 8734.94% in 2021, then slumped by 98 bps to 194.99% in 2022, then tumbled by 81 bps to 37.09% in 2023, then tumbled by 140 bps to 14.98% in 2024, then sank by 6620 bps to 1006.6% in 2025.
• According to Business Quant data, Net Margin over the past three periods registered 1006.6%, 1599.78%, and 17.82% for Q3 2025, Q2 2025, and Q1 2025 respectively.